Research Analysts’ Downgrades for September 27th (AGIO, BMBL, CLDX, CPB, DG, DLNG, ESPR, FITB, HOLX, HPQ)

Research Analysts’ downgrades for Friday, September 27th:

Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by analysts at Leerink Partners from an outperform rating to a market perform rating. Leerink Partners currently has $56.00 price target on the stock, down from their previous price target of $60.00.

Bumble (NASDAQ:BMBL) was downgraded by analysts at KeyCorp from an overweight rating to a sector weight rating.

Celldex Therapeutics (NASDAQ:CLDX) was downgraded by analysts at Wolfe Research from an outperform rating to a peer perform rating.

Campbell Soup (NASDAQ:CPB) was downgraded by analysts at DA Davidson from a buy rating to a neutral rating. They currently have $51.00 price target on the stock.

Dollar General (NYSE:DG) was downgraded by analysts at Citigroup Inc. from a neutral rating to a sell rating. The firm currently has $73.00 target price on the stock, down from their previous target price of $91.00.

Dynagas LNG Partners (NYSE:DLNG) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Esperion Therapeutics (NASDAQ:ESPR) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Fifth Third Bancorp (NASDAQ:FITB) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Hologic (NASDAQ:HOLX) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

HP (NYSE:HPQ) was downgraded by analysts at Bank of America Co. from a buy rating to a neutral rating. They currently have $37.00 price target on the stock.

iRhythm Technologies (NASDAQ:IRTC) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Medpace (NASDAQ:MEDP) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Medpace (NASDAQ:MEDP) was downgraded by analysts at UBS Group AG from a buy rating to a neutral rating. They currently have $350.00 price target on the stock, down from their previous price target of $420.00.

McGrath RentCorp (NASDAQ:MGRC) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Summit Therapeutics (NASDAQ:SMMT) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating. Citigroup Inc. currently has $23.00 target price on the stock, up from their previous target price of $19.00.

Ubisoft Entertainment (OTCMKTS:UBSFY) was downgraded by analysts at HSBC Holdings plc from a buy rating to a hold rating.

Udemy (NASDAQ:UDMY) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating. Morgan Stanley currently has $7.50 price target on the stock, down from their previous price target of $10.00.